Free Trial

Arteris, Inc. (NASDAQ:AIP) CEO Sells $601,329.96 in Stock

Arteris logo with Computer and Technology background

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 58,212 shares of the stock in a transaction dated Monday, December 30th. The shares were sold at an average price of $10.33, for a total transaction of $601,329.96. Following the completion of the sale, the chief executive officer now owns 10,020,588 shares of the company's stock, valued at approximately $103,512,674.04. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

K Charles Janac also recently made the following trade(s):

  • On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The stock was sold at an average price of $10.42, for a total value of $631,285.28.
  • On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $141,941.80.
  • On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The shares were sold at an average price of $10.12, for a total transaction of $180,702.72.
  • On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The stock was sold at an average price of $8.58, for a total value of $10,656.36.

Arteris Stock Up 16.7 %

Shares of NASDAQ:AIP traded up $1.70 during trading on Thursday, hitting $11.89. The company's stock had a trading volume of 1,350,670 shares, compared to its average volume of 169,888. The company has a market capitalization of $477.70 million, a PE ratio of -12.39 and a beta of 1.25. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. Arteris, Inc. has a fifty-two week low of $4.83 and a fifty-two week high of $11.90. The business has a 50 day moving average price of $8.79 and a two-hundred day moving average price of $8.03.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities reaffirmed a "buy" rating and set a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

Check Out Our Latest Stock Report on AIP

Institutional Investors Weigh In On Arteris

Several large investors have recently bought and sold shares of AIP. Needham Investment Management LLC increased its holdings in Arteris by 14.7% in the third quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company's stock valued at $21,114,000 after buying an additional 350,000 shares during the last quarter. Essex Investment Management Co. LLC purchased a new position in shares of Arteris in the 3rd quarter valued at about $2,504,000. Bank of New York Mellon Corp acquired a new stake in shares of Arteris during the 2nd quarter worth about $580,000. CloudAlpha Capital Management Limited Hong Kong purchased a new stake in Arteris during the second quarter worth approximately $554,000. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in Arteris by 36.3% in the third quarter. Jacobs Levy Equity Management Inc. now owns 253,211 shares of the company's stock valued at $1,955,000 after purchasing an additional 67,414 shares in the last quarter. Hedge funds and other institutional investors own 64.36% of the company's stock.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

→ Buy this Stock before Trump Takes Office! (From Behind the Markets) (Ad)

Should you invest $1,000 in Arteris right now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Rivian Stock Surge Analysis: Long-Term Potential or Short-Term Play?
The Future of Healthcare: 3 AI Stocks Leading the Way
Analysts Predict Big Gains for These 3 Cybersecurity Leaders

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines